文献速递消化系统肿瘤

结肠镜筛查阴性后的结直肠癌发病率和死亡率

Colorectal Cancer Incidence and Mortality After Negative Colonoscopy Screening Results.
PubMed 文献 · JAMA Oncol · 2025-01-01

该队列研究纳入美国三项前瞻性人群队列共195 453名参与者,随访中位12年,发现结肠镜筛查阴性结果与20年内结直肠癌发病率(HR 0.51,95%CI 0.44-0.58)和死亡率(HR 0.56,95%CI 0.46-0.70)降低相关。在筛查阴性者中,中危(评分6-7)和低危(评分0-5)个体分别至初次筛查后16年和25年才达到高危(评分8-12)个体10年累积发病率0.78%。

要点

  • 结肠镜筛查阴性结果与20年内结直肠癌发病和死亡风险降低相关。
  • 中危个体至16年、低危个体至25年才达到高危个体10年累积发病率0.78%。
  • 研究为低风险特征个体延长再筛查间隔至10年以上提供共同决策证据。

核心结论

  • 结肠镜筛查阴性结果与20年内结直肠癌发病率和死亡率降低相关。
  • 中危和低危个体达到高危个体10年累积发病率0.78%的时间分别延迟至16年和25年。
  • 研究结果为医患共同决策考虑将再筛查间隔延长至目前推荐的10年以上提供证据,尤其对低风险特征个体。

研究设计与样本

  • 队列研究,纳入美国护士健康研究、护士健康研究II和卫生专业人员随访研究三项前瞻性人群队列。
  • 随访时间从1988年和1991年至2020年。
  • 共195 453名参与者,基线中位年龄44岁(IQR 37-56),81%为女性。
  • 中位随访12年(IQR 6-20)。
  • 使用2017年1月1日至2018年12月31日周期的美国国家健康与营养调查数据比较风险特征分布。

主要发现

  • 81 151名有结肠镜筛查阴性结果者中记录394例结直肠癌和167例结直肠癌死亡;114 302名无内镜检查者中记录2229例结直肠癌和637例结直肠癌死亡。
  • 结肠镜筛查阴性结果与20年内结直肠癌发病率降低相关(HR 0.51,95%CI 0.44-0.58)。
  • 结肠镜筛查阴性结果与20年内结直肠癌死亡率降低相关(HR 0.56,95%CI 0.46-0.70)。
  • 在筛查阴性者中,中危(评分6-7)和低危(评分0-5)个体分别至初次筛查后16年和25年才达到高危个体(评分8-12)的10年累积发病率0.78%。

关键数值与推荐

  • 高危个体(评分8-12)10年累积结直肠癌发病率为0.78%。
  • 中危个体(评分6-7)至初次筛查后16年达到该累积发病率。
  • 低危个体(评分0-5)至初次筛查后25年达到该累积发病率。

临床怎么用

  • 研究结果为医患共同决策考虑将结肠镜筛查阴性后的再筛查间隔延长至目前推荐的10年以上提供证据,尤其对低风险特征个体。
  • 作者认为决策结肠镜再筛查时应考虑已知的结直肠癌风险因素。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: The current recommendation for a 10-year rescreening interval after a negative colonoscopy screening (NCS) result has been questioned, with some studies showing a persistently lower risk of colorectal cancer (CRC) after NCS results. OBJECTIVE: To examine long-term CRC incidence and mortality after NCS results (ie, no presence of CRC or polyps) and according to a risk score based on major demographic and lifestyle risk factors. DESIGN, SETTING, AND PARTICIPANTS: In this cohort study, 3 prospective US population-based cohorts from the Nurses' Health Study, Nurses' Health Study II, and Health Professionals Follow-up Study were followed up from 1988 and 1991 to 2020. Data from the National Health and Nutrition Examination Survey (NHANES) from the January 1, 2017, to December 31, 2018, cycle were used to compare the risk profile distribution with that of the general US population. Data analysis was performed from October 2023 to August 2024. EXPOSURES: Time-varying status of NCS results and risk score. MAIN OUTCOMES AND MEASURES: Cox proportional hazards regression was used to calculate hazard ratios (HRs) and 95% CIs for incidence and mortality of CRC. RESULTS: A total of 195 453 participants (median [IQR] age, 44 [37-56] years at baseline; 81% female) were followed up for a median (IQR) of 12 (6-20) years. Among 81 151 individuals with NCS results and 114 302 without endoscopy, 394 and 2229 CRC cases and 167 and 637 CRC deaths, respectively, were documented. Negative colonoscopy screening results were consistently associated with lower CRC incidence (HR, 0.51; 95% CI, 0.44-0.58) and mortality (HR, 0.56; 95% CI, 0.46-0.70) for 20 years. Among individuals with NCS results, those with an intermediate risk (scores, 6-7) and low risk (scores, 0-5) did not reach the 10-year cumulative incidence of CRC (0.78%) of the high-risk individuals (scores, 8-12) until 16 and 25 years after initial screening, respectively. CONCLUSION AND RELEVANCE: These findings provide evidence for shared decision-making between patients and physicians to consider extending the rescreening intervals after an NCS result beyond the currently recommended 10 years, particularly for individuals with a low-risk profile. These results showed, as a proof of concepts, the importance of considering known CRC risk factors when making decisions for colonoscopy rescreening.

来源:JAMA Oncol,查看原文。版权归原作者所有。

引用

  1. Knudsen MD, Wang K, Wang L, et al. Colorectal Cancer Incidence and Mortality After Negative Colonoscopy Screening Results. JAMA Oncol. 2025. PMID: 39602147. doi:10.1001/jamaoncol.2024.5227

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。